Yuki Tachibana

ORCID

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Venues

Journal of medicinal chemistry

The Journal of antimicrobial chemotherapy

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Shuhei Yoshida, Yusuke Sako, Eiji Nikaido, Taichi Ueda, Iori Kozono, Yusuke Ichihashi, Atsufumi Nakahashi, Motoyasu Onishi, Yukiko Yamatsu, Teruhisa Kato, Junichi Nishikawa, Yuki Tachibana
Peptide-to-Small Molecule: Discovery of Non-Covalent, Active-Site Inhibitors of β-Herpesvirus Proteases. ACS medicinal chemistry letters 14 (11) (2023)
Takayuki Kuroda, Haruaki Nobori, Keita Fukao, Kaoru Baba, Kazumi Matsumoto, Shinpei Yoshida, Yukari Tanaka, Ryosuke Watari, Ryoko Oka, Yasuyuki Kasai, Kae Inoue, Sho Kawashima, Alice Shimba, Yoko Hayasaki-Kajiwara, Miki Tanimura, Qianhui Zhang, Yuki Tachibana, Teruhisa Kato, Takao Shishido
Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2 in vitro and in vivo. The Journal of antimicrobial chemotherapy (2023)
Eiichi Kojima, Atsuhiro Iimuro, Mado Nakajima, Hirotaka Kinuta, Naoya Asada, Yusuke Sako, Zenzaburo Nakata, Kentaro Uemura, Shuhei Arita, Shinobu Miki, Chiaki Wakasa-Morimoto, Yuki Tachibana
Pocket-to-Lead: Structure-Based De Novo Design of Novel Non-peptidic HIV-1 Protease Inhibitors Using the Ligand Binding Pocket as a Template. Journal of medicinal chemistry 65 (8) (2022)
Haruaki Nobori, Keita Fukao, Takayuki Kuroda, Naomi Anan, Ryoichi Tashima, Masaaki Nakashima, Sayuri Noda, Minako Tajiri, Mikinori Torii, Shinsuke Toba, Kentaro Uemura, Takao Sanaki, Takao Shishido, Yuki Tachibana, Teruhisa Kato
Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model. The Journal of antimicrobial chemotherapy 77 (11) (2022)
Shuhei Yoshida, Shota Uehara, Noriyasu Kondo, Yu Takahashi, Shiho Yamamoto, Atsushi Kameda, Soichiro Kawagoe, Naoko Inoue, Masami Yamada, Norito Yoshimura, Yuki Tachibana
Peptide-to-Small Molecule: A Pharmacophore-Guided Small Molecule Lead Generation Strategy from High-Affinity Macrocyclic Peptides. Journal of medicinal chemistry 65 (15) (2022)
Yuto Unoh, Shota Uehara, Kenji Nakahara, Haruaki Nobori, Yukiko Yamatsu, Shiho Yamamoto, Yuki Maruyama, Yoshiyuki Taoda, Koji Kasamatsu, Takahiro Suto, Kensuke Kouki, Atsufumi Nakahashi, Sho Kawashima, Takao Sanaki, Shinsuke Toba, Kentaro Uemura, Tohru Mizutare, Shigeru Ando, Michihito Sasaki, Yasuko Orba, Hirofumi Sawa, Akihiko Sato, Takafumi Sato, Teruhisa Kato, Yuki Tachibana
Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19. Journal of medicinal chemistry 65 (9) (2022)

Yuki Tachibana.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yuki Tachibana